Nigeria has received a major boost in its fight against HIV with the introduction of Lenacapavir, a long-acting prevention injection.

The medication was approved by the Coordinating Minister of Health and Social Welfare, Ali Pate, with support from the Global Fund.

Lenacapavir is designed for pre-exposure prophylaxis (PrEP), helping people at risk of HIV infection stay protected. Unlike daily pills, the injection is administered only twice a year, making it a more convenient option for many individuals who struggle with regular medication.

According to Adebobola Bashorun of the National HIV Viral Hepatitis and STDs Control Programme, the arrival of the drug reflects Nigeria’s commitment to adopting modern medical solutions. He explained that expanding prevention tools will help reduce new infections and improve public health outcomes.

Health officials say the drug will soon be available in Nigeria and more than 100 other low- and middle-income countries at an estimated cost of about $40 per person yearly.

The rollout is expected to strengthen Nigeria’s goal of ending HIV as a major public health threat.